532 veterinary practices responded to the survey, which was sent to 3,096 veterinary practices for which the RCVS had a unique email address, on 3rd April.
The survey found that:
Three-quarters of those who responded to the survey answered a question on how the RCVS could better support veterinary practices through the crisis. The most frequent response (27%) was that the RCVS needed to provide clearer guidance, in particular as to what services it was permissible for veterinary practices to provide [the College published its updated guidance and flowchart on 9 April].
Of those who responded to the question, 15% felt that the RCVS was doing a good job or that there was nothing more it should do, while just 2% of responses expressed negative sentiment towards the RCVS.
Lizzie Lockett, RCVS Chief Executive, said: “I would like to thank all those practices who took the time in what is already a very fraught situation to respond to our survey and provide the evidence we need to gain a holistic picture of coronavirus’ impact on the business and economics of veterinary practices. We plan to continue running these surveys on a regular basis in order to gauge impact over time and the findings will feed into our policy and decision-making.
"This ongoing research will also be a vital tool when we are talking to Government and other bodies about the impact of policy on the veterinary sector. On this note, we are aware of the challenges of a minimum furlough period of three weeks given the need for practices to take steps to offer 24/7 emergency and critical care, and have written to government on this with some case studies around the impact this is having.
"To those on the ground it won’t come as too much of a surprise that the impact of the coronavirus has been profound in areas such as practice turnover and staffing, with many vets, veterinary nurses and other support staff being furloughed with the aim of signing them up to the Government’s Coronavirus Job Retention Scheme.
"There are some bright spots in the data we’ve gathered – very few practices reported that they had made or were planning to make staff redundant, and many practices reported mitigating the challenge of social distancing by carrying out consultations with new and existing clients remotely.
"Since the survey took place we have also taken steps to meet some of the requests for greater clarity and guidance from the RCVS with the publication of our flowchart helping practices to decide what treatments it is appropriate to carry out safely amidst the COVID-19 pandemic."
The survey results can be read in full at www.rcvs.org.uk/publications.
The next practice impact survey is planned for early May.
Julie Dugmore, RCVS Director of Veterinary Nursing, said: "We have been in discussion with veterinary nursing education providers regarding a number of concerns they have raised regarding the support for student veterinary nurses and the progression with their licence to practise qualifications.
"These include concerns that, under the current circumstances, student veterinary nurses would not be able to fulfil their clinical placement requirements, as well as not being able to undertake the required assessments. Furthermore, institutions offering veterinary nurse education would not be able to continue their programme of approving and quality monitoring Training Practices.
"Therefore the following temporary arrangements and guidance have been approved by both the Veterinary Nurses (VN) Education Committee and VN Council. We ask that all student veterinary nurses, veterinary nursing education centres and Training Practices read the guidance.`'
The temporary arrangements and guidance are as follows:
Clinical placements
Several universities have expressed concerns regarding student veterinary nurses’ attendance in clinical placement over the coming weeks, due to the precautions around transmission of Coronavirus. This applies, in the main, to full-time students in all years of a programme, although there are particular concerns as to the impact this will have on final-year students being unable to complete the required number of hours in order to complete their programme and graduate.
Universities and awarding organisations have requested a degree of flexibility around the RCVS VN Registration Rules and completion of the RCVS Day One Skills, in light of the Covid-19 situation. The following therefore applies:
We recognise that it should not be compulsory for students to complete clinical placements within the next eight weeks, after which the situation will be reviewed. This will apply to students in any year of their studies.
We recognise that for students in their final year of study, it may be difficult for them to make up the hours of clinical placement missed prior to graduation. Universities and colleges should continue to support students and explore alternatives, however any shortfall relative to the requirements should not be a barrier to completion of the programme.
For BSc students in years 1 to 3 of their studies and FdSc students in years 1 and 2 of their studies, we would expect that there will be sufficient time for them to make up the number of hours prior to completing the programme. However we will review this as the Covid-19 pandemic progresses.
Student veterinary nurses will still be required to complete the Day One Skills for Veterinary Nurses in their totality as these seek to assure competency at the point of registration. Where a student has completed the Day One Skills in less than the 1,800 hours, this will be assessed on a case by case basis on application to register.
Assessments
We note that accreditation standards require veterinary nursing programmes to include an OSCE or similarly robust, objective and evidence-based form of practical examination to test safe and effective acquisition of a broad range of skills and competences as outlined in the RCVS Day One Competences and Skills for Veterinary Nurses.
There has been some concern regarding the number of examiners required for OSCE assessments in light of announcements from some organisations that are not allowing staff members to attend large gatherings.
Universities and awarding organisations may need to explore alternatives to the current delivery of the unseen and Objective Structured Clinical Examination (OSCE) used for assessment of the RCVS Day One Competences and Skills for Veterinary Nurses, as a result of measures to protect students and staff and reduce the risk of Coronavirus transmission. In this respect, the RCVS Examinations Manager and Chair of VN Education Committee will review proposals for changes to the assessment.
As universities and awarding organisation explore alternative methods, they should continue to consider the robustness of their processes in assessing practical skills.
Universities and awarding organisations will still be required to assure us, through subsequent analysis and evaluation, that all their assessments were sufficiently met Day One Competences and Skills.
Training Practice Approval and Quality Monitoring activities
Time spent discussing the articles can be claimed towards the annual CPD requirement by pressing the ‘Claim CPD’ link at the top of the forum discussion thread.
The first article up for discussion is "Newborn resuscitation following dystocia or caesarean section", by Tom Towey MRCVS who will be joining us in the forum this week.
Tom is an RCVS Advanced Practitioner in Emergency & Critical Care working at Vets Now in Manchester.
He graduated from the University of Glasgow in 2011, before spending 7 years at Petmedics Emergency Hospital in Manchester.
He gained his Advanced Practitioner status in Emergency and Critical Care in 2016 and joined Vets Now in 2018.
He now lectures on a wide variety of aspects of emergency care .
VetNurse.co.uk Clinical Editor Alasdair Hotston Moore said: “For veterinary nurses, I think this adds a really valuable extra dimension to your clinical reading. “It’s not just the opportunity to ask questions of the author, but also to discuss the implications and practicalities of the article amongst yourselves. VetNurse.co.uk Editor, Arlo Guthrie said: “More than that, it’s also in a closed professional community where you can be 100% confident of a friendly atmosphere and authoritative opinions with provenance. “And more even than that, the questions you ask and the discussion you have are then available as a useful, searchable resource for everyone in the profession.” So do come and join in. First read the article here: https://www.veterinary-practice.com/article/newborn-resuscitation Then come and join the discussion here: https://www.vetnurse.co.uk/001/veterinary-nurse-clinical/small-animal/f/misc-clinical-discussions/32369/new-clinical-article-club-newborn-resuscitation-following-dystocia-or-caesarean-section-with-tom-towey
Aimed at all members of the veterinary team across Europe, the webinar is moderated by veterinary nutrition expert Dottie Laflamme.
The webinar, which will also be available on demand after the event, follows others in the series that allow conversations about nutrition to be integrated into everyday consultations.
Speakers Shoshanah Verton Shaw, RVT, VTS (nutrition) (pictured right), and Marge Chandler (a diplomate of the American College of Veterinary Internal Medicine, the European College of Veterinary Internal Medicine and the American College of Veterinary Nutrition) will be sharing their tips for handling nutrition discussions in a non-confrontational way that preserves the client bond with the vet and the practice.
Registration for this and another three free webinars is available at https://bit.ly/purinawebinars2022.
Looking at the imagery on the company's website, I'm not altogether sure I'll be able to resist it either.
The new range, which comes in chicken or tuna flavour with vegetables and rice, includes:
Urinary Care - to help dissolve struvite uroliths
Derm Defense - to support skin health
Digestive Care - for pets with gastrointestinal disorders and pets in recovery
Metabolic - a weight management diet for pets
Kidney Care - to support pets with kidney conditions
For more information, visit: https://www.hillspet.co.uk/prescription-diet/stew.
The study1, the largest in the world to date, investigated anonymised veterinary clinical records of a random sample of almost 4,000 hamsters.
The three most common hamster species were Syrian (golden) hamster (73.5%), Djungarian (winter white dwarf) hamster (13.8%) and Roborovski hamster (6.4%).
From a list of the 20 most common disorders across all hamster species, the most common disorders were "wet tail" – (diarrhoea or liquid discharge) (7.33%), bite injuries from other hamsters (5.88%), overgrown nails (4.13%), overgrown front teeth (3.98%) and traumatic injury (3.80%).
The average age at death across all hamsters was 21 months (1.75 years).
The RVC says a better awareness of the average lifespan of pet hamsters should help veterinary surgeons build realistic expectations for hamster owners and may also help owners accept the animal welfare benefit for euthanasia.
It is also helpful to help children understand the typical natural lifecycle of pet hamsters.
Other findings included:
Dr Dan O’Neill, Associate Professor in Companion Animal Epidemiology at the RVC and lead author of the paper, said: “Hamsters can make good pets for both adults and children but until now, very little was published about their health.
"Parents can now help their children with realistic expectations of how long their hamster may live and what are the most common conditions to look out for to protect the health of these delightful little creatures.”
The RVC has an advice sheet on hamster care here: https://rvc.uk.com/hamster-care.
Reference
Everyone taking part in the survey will receive a fob watch to thank them for their participation.
Sarah is leading the project, which is supported by Ceva Animal Health, alongside Professor Danièlle Gunn-Moore, fellow RCVS Feline Medicine Specialist and Professor in Feline Medicine at The University of Edinburgh.
Suzanne Page MRCVS, Amodip Product Manager at Ceva, said: “There are many barriers to ensuring that all older cats and those with relevant concurrent diseases receive screening for hypertension.
"The survey will help us better understand what those barriers are and how these challenges can be addressed positively to improve animal welfare.
"It is also an issue that requires the whole practice team to come together to deliver a better outcome for their patients.
"We are therefore very keen to find out how all members of the practice team view these important issues and want to encourage all vets and veterinary nurses to share their perspective on the challenges they face in carrying out blood pressure measurements.”
Sarah is emphasising the importance of keeping feline patients calm and relaxed during blood pressure assessments: “The so-called ‘white coat effect’ or situational hypertension, has been observed in both people and animals.
"The survey will also explore the tools and techniques veterinary professionals use to minimise the impact of blood pressure assessments on their patients and will help us to develop some best practice approaches.”
The survey can be found at https://bit.ly/FelineHypertensionSurvey.
The review started with a series of focus groups amongst veterinary professionals across multiple sectors.
This was followed by an analysis of the information gleaned from the focus groups, additional stakeholder submissions, data from the College's Covid surveys, independent research studies and formal legal advice to formulate an online qualitative survey to gain the views and feedback of UK-based veterinary professionals.
In this final stage, the public consultation, all veterinary professionals, vet and vet nurse students, practice managers and all those who work in the veterinary practice team are invited to share the extent to which they agree (or disagree) with each element of the proposed new guidance on ‘under care’, their views on the requirements for a 24/7 follow-up service following a remote prescription and other safeguards, and their feedback on the proposed definition of limited-service providers.
There will also be a consultation with members of the animal-owning public, which will likely include questions asking for information about animal owner experiences with remote prescriptions, the perceived advantages and/or disadvantages of remote prescribing, and views on 24/7 care and how important a service this is to respondents.
Dr Melissa Donald MRCVS, RCVS President and former Chair of the Standards Committee, said: “The past two years have shown us that the veterinary professions are highly capable of adopting new ways of working.
"It also revealed that we can adapt our established ways of practice to better respond to shifts in public expectations and advancements in technology.
"However, it is our collective responsibility to ensure that any changes continue to allow us to provide safe and effective care for our patients, and meet the appropriate expectations of our clients.
“Whilst we recognise and reflect on the need for change, the proposed guidance seeks to protect animal health and welfare and maintain public trust by ensuring that decision-making remains firmly in the hands of individual veterinary surgeons, as to what they, in their professional judgement, consider appropriate in a specific situation.
“This consultation, then, while not a referendum on whether RCVS guidance on ‘under care’ and 24-hour emergency first-aid and pain relief should change – that decision having been made by Standards Committee and approved by Council based on the evidence gathered, including the views of the profession and objective evidence, and legal advice – is a crucial opportunity for veterinary colleagues to tell us whether we have got the draft guidance right, whether the proposed safeguards are sufficient, and whether there is anything we might have missed or should amend.”
www.rcvs.org.uk/undercare.
The acquisition of Jurox brings Zoetis a valuable animal health portfolio, including Alfaxan, a leading anaesthetic product for companion animals and high-quality local R&D and manufacturing operations in Australia.
Stephanie Armstrong, Senior Vice President and Cluster Lead UK, BeNeLuX, Nordics & Ireland, said: “We are grateful to the O’Brien family for entrusting the future of this family-owned business to Zoetis.
"Jurox’s portfolio plays to the strengths of our core business and will be a complementary fit with the solutions we deliver to veterinary professionals, livestock producers and pet owners.
"With Zoetis’ global sales and regulatory expertise in more than 45 direct markets, we look forward to expanding the impact and reach of the entire Jurox portfolio here in the UK and Ireland.”
www.jurox.com
Using practices developed for human healthcare measurement, NewMetrica developed VetMetrica, which the company says can measure how an animal “feels” about its circumstances from its individual perspective.
Jim Brick, Vice President Commercial Development and Lifecycle and Innovation at Zoetis said: "This novel approach supports a significant shift in veterinary care and animal welfare more generally towards the attainment of good or excellent quality of life in companion animals.
"The benefits of NewMetrica’s digital instruments have been validated through scientific publications and the FDA, and the EMA has confirmed the algorithms that produce the results.”
Jamie Brannan, President International Operations, Zoetis added: "We expect NewMetrica’s tools and algorithms to support earlier detection and treatment of diseases as we gain more insight into the quality of life of our pets and be an important element of future product development.
“NewMetrica’s instruments will give us scientifically validated results for alleviation of OA pain that veterinarians and pet owners will appreciate and value.”
https://www.newmetrica.com
To claim the free product, visit www.daxocox.co.uk/trial and use the stock selector to pick the dose sizes to suit the patients you think Daxocox could help.
Animalcare Marketing Manager James Beaumont explained: “When you consider that recent data shows that up to 20% of dogs over one year of age could have some form of OA1, the scale of problem becomes clear – as does the threat to the welfare of our canine companions from OA pain.
“Owners already giving Daxocox to their OA-affected pets, have seen first-hand how it can significantly improve their quality of life.
"90% said that their dog’s osteoarthritis improved, with 84% reporting that their dog’s quality of life improved from “poor or fair” to “good, very good or excellent.”2
James added: “In a study carried out by Animalare, 88% of owners said that weekly NSAID dosing would be easier to remember, or mean they were less likely to miss a dose or that it would control their dog’s pain more effectively.3
“Used as a first line treatment for OA, Daxocox can provide a solid foundation to long-term pain management that suits vets, dogs and their owners.
"As such, we’re confident that once practices have tried it, it will become their canine OA NSAID of choice.”
For more information, visit www.daxocox.co.uk
References
The company says the reason for the change is so that it can dedicate additional resources to the business.
Samantha Williamson, UK Country Manager at Animalcare, said: "Through our identichip microchips and our identibase pet database, we provide one of the UK’s longest-established pet microchipping services and are helping to reunite owners with their lost pets every single day.
"The pet reunification sector is evolving rapidly thanks to technological advances. We believe that the creation of identicare will facilitate the concentration of resources and expert knowledge needed to fuel the growth in our identichip business and continued enhancements to the identibase pet database. identicare will share the same passion and values as Animalcare and there will be no outward change for our customers.
“We look forward to continuing to deliver our ambition of delivering the highest quality pet reunification service under the identicare banner.”
The new company is part of the Animalcare Group.
The collection includes articles from BSAVA’s Companion magazine, webinars, and Congress lectures, covering topics such as ‘What does environmentally-friendly look like in practice?’, ‘20x20 visions of a greener future now’, and ‘One Health, One Planet: Why sustainability is a necessity’.
The collection builds on the work of the BSAVA Sustainability Working Group (SWG), which was formed to help small animal practices on their sustainability journey.
Carl Gorman, Junior Vice President of the BSAVA and Chair of the SWG said: “We are pleased to have created this collection of resources for veterinary professionals.
"It is increasingly important that we ensure sustainable working in small animal practice, and we hope that this collection highlights some of the ways in which staff can really make a difference in their practice”.
The collection is freely available in the BSAVA Library throughout December from: https://www.bsavalibrary.com/content/sustainability-in-practice
To find out more about the BSAVA SWG’s work, visit: https://www.bsava.com/aboutus/sustainability
Dr Guillaume Leblond, an American specialist in veterinary neurology at NDSR said: “Traditionally, bone cement has been used to provide support and stabilisation when treating veterinary spinal instability cases.
“Polyaxial pedicle screws have proven a very reliable and efficient way of treating such spinal problems in human medicine.
“These special screws can be inserted in the vertebrae and connected to strong metal rods instead of bone cement and we’re now very excited to be offering this new service to our patients.
“The main advantage to this cutting-edge procedure is its flexibility.
"Once cement is set in place it is obviously very hard to move, manipulate or remove should you need to adjust or correct.
“With the metal rod and screw system, it is more adaptable and you can adjust it far more easily and quickly.
“It may also be less prone to infection compared to cement, which has been known to harbour bacteria sometimes causing infections several years after the surgery.
"Another hope we have for this system is that it will be less prone to failure compared to cement, especially on extended stabilisation constructs.
Guillaume added: “The neurology team at NDSR has been training in applying this new system as soon as it became available and we have already used it to treat two dogs, both of them having surgery on the same day.
“One was a golden retriever treated by my colleagues Rodolfo Cappello (head of neurology) and Natalie West (neurology resident), and the other was a whippet under my care.
"They were two very different sizes of dog but both operations went well.
“We are grateful to OrthomedTM, the company manufacturing the stabilization system, provided all necessary details to plan the surgeries as precisely as possible.
“We also collaborated with Vet3DTM to create patient specific 3D printed guides to ensure the precise placement of screws and it proved a great solution in both cases.”
“Admittedly, it is still early days for the introduction of this new spinal stabilisation system but we are optimistic it will prove a significant advancement in treating many spinal problems.”
www.ndsr.co.uk
In mid-September, the Association wrote to the RCVS expressing concern about the August extension to the temporary guidance.
In the latest update from the RCVS, the temporary measure has now been extended to 31 October but the flowchart and guidance have been updated to add some additional steps before a POM-V product can be prescribed remotely.
The BVA says that while it supported the original decision in March as a pragmatic solution and direct response to government restrictions surrounding Covid-19, it is now questioning the ongoing need for such a relaxation in the rules.
In the letter to the RCVS, the BVA also asked for a timeframe for the publication of the results of the RCVS survey of practices’ experiences of remote consulting and prescribing. The Association's own under care working group, chaired by Nigel Gibbens, has been developing a position to respond to the RCVS review.
BVA President James Russell (pictured right) said: "We understand that allowing remote prescription of POM-Vs was a necessary measure at the height of the lockdown, as practices struggled to assess patients in person.
"However, the veterinary professions have done a fantastic job in adapting to the restrictions and are now able to work safely and see patients.
"Whilst we recognise the RCVS has provided additional guidance for the remote prescribing of POM-V, we cannot currently see any reason why a new client would be unable to access in-person veterinary care in the first instance and we are asking RCVS Council to reconsider this measure when it meets in Oct.
"It makes sense to continue allowing vets to remotely prescribe for existing patients, for example if an owner is shielding, but we feel it is no longer appropriate to be remotely prescribing to animals that have never been physically examined by the vet.
“The question of whether we should be able to remotely prescribe POM-V products without first seeing an animal is an important and live debate, and we welcome the resumption of the College’s review. But the longer that temporary measures are in place, the greater the expectation from animal owners that they will always be in place, and the harder it will be to have the discussion about the best way forward.
“As a profession, we are rightly concerned about antimicrobial resistance and we pride ourselves on the responsible use of medicines. Continually extending the temporary measures without a full analysis would risk undermining our position.”
Amy was diagnosed with a rare form of cancer in 2019 and treated at the Bristol Royal Infirmary, Bristol Haematology and Oncology Centre and Southmead Hospital.
She underwent cancer surgery, chemotherapy and radiotherapy, and afterwards wanted to show her appreciation for the expert care she’d received by supporting the charity Above and Beyond, which raises money for Bristol City Centre Hospitals.
Unfortunately, the pandemic put paid to her plans for a fundraising event, so instead, Amy decided to sell Christmas trees from home and donate a percentage of the profits to the charity.
Amy said: “I wanted to give something back in return for the wonderful care the hospitals provided me with.
"The people who work in this field truly are angels and made a terrifying road ahead much easier to get through. I really do not know how some of them do the jobs that they do.
"The charity Above and Beyond raises money for Bristol City Centre Hospitals, including the children’s hospital, so I decided to pick them so that all the hospitals that had been involved in my care would benefit."
Amy managed to sell 102 trees, well surpassing her original target of 70. She added: "I am extremely thankful to everyone who chose to support me and the charity. We had raised more than £2,000 by the end of January, which is fantastic.
"I hope everyone enjoyed their beautiful real trees and I look forward to seeing them all again next year!"
Cave’s clinical director Nele Van den Steen said: “This was a wonderful effort by Amy and typical of her caring and considerate nature."
Vikaly is indicated for the nutritional and medical management of chronic kidney disease in adult and senior cats with proteinuria, from IRIS stage 2.
The new diet delivers the same therapeutic dosage as benazepril tablets (0.5–1 mg/kg bodyweight/day).
Nutrition-wise, Vikaly is low phosphorus (0.5% as fed), has reduced protein (30% as fed), contains omega-3 fatty acids (1.2%, including 0.6% EPA & DHA) and offers high metabolisable energy (416 kcal/100g).
Virbac highlights data showing that CKD remains the leading cause of mortality in cats over five years old and affects up to 40% of feline patients over the age of ten1,2.
The company says administering daily treatment is recognised as a major issue for CKD cat owners with 45% of owners not administering treatment daily as they should and 51% of owners citing administration difficulties as the reason why3.
This new product eliminates the need to administer medication separately, which could completely transform treatment compliance, removing the risk of missed doses and reducing stress for both cats and their owners.
Virbac says that due to the pharmacokinetic profile of benazepril, which is incorporated into the kibble, at an equivalent dose Vikaly displays greater ACE inhibition than benazepril tablets4.
The rate of food consumption also does not affect plasma Benazeprilat levels, ensuring consistent treatment efficacy regardless of the cat’s feeding behaviour5.
Virbac says that in practice, this means that even if the cat being treated consumes less than 50% of their daily ration, efficacy is maintained with ACE activity similar to that of benazepril tablets.
Benazepril has a wide therapeutic margin, tolerated to 20x the minimum effective dose (10mg/kg) for 52 weeks, with the first signs of toxicity being reduced erythrocytes counts & ovary/oviduct weights6.
Virbac says that with Vikaly, these levels cannot be reached because the active ingredient is contained in food, which would require a cat to consume more than 10 times their daily ration.
Vikaly is presented in a 1.5kg bag, which equates to a 30 day supply for a 4.5kg cat with normal bodyweight.
It can be fed alongside wet food, providing that the cat consumes at least 50% of their daily ration before being given the wet food.
The daily ration can also be administered in several smaller meals throughout the day, to accommodate the individual preferences of the cat and to promote consistent food intake.
Vikaly is a prescription diet. Or 'POD', I guess.
So far this year the charity says it has received 144 requests from people asking for it to take in or help rehome their horse or pony through the Blue Cross Home Direct service.
More than 70% cited personal or financial circumstances as the reason.
In comparison for the full year of 2021, 43 (or around 15%) of a total of 277 intake and rehoming requests specified financial reasons.
In 2020 a total of 32 (around 14%) out of 231 requests stated financial reasons.
Annabelle Taylor, Rehoming Coordinator at Blue Cross, said: “It is distressing to see that the number of people seeking rehoming support because of financial reasons is already more than double last year’s annual total and we still have a third of the year to go.
The range comprises four products: Calm, Seb, Pyo and Care. All four contain a new active ingredient derived from Ophiopogon japonicus called ophytrium, which Ceva says has been shown to strengthen the mechanical skin barrier1, restore the balance of protective microbial flora2 and sooth the skin1.
The new range consists of both shampoo and mousse formulations: Douxo S3 Calm is designed to sooth itchy, irritated skin while maintaining the skin barrier. Douxo S3 Pyo contains ophytrium and chlorhexidine at 3% which is both antibacterial and antifungal. Douxo S3 Seb contains ophytrium and seboliance and includes an extract from the peel of pomegranate. Ceva says it has an anti-odour action and will help with oily or flaky skin. Lastly, Douxo S3 Care (available as a shampoo only) contains ophytrium and is designed for regular use and maintenance.
The products are all free from soap, parabens, sulphates, phthalates, colourants and nanoparticles. A new, hypoallergenic ‘summertime’ fragrance has been added to the range which pet owners apparently liken to coconut and vanilla.
The Douxo S3 range comes in eye-catching packaging with a pump that can be used with one hand, an ergonomic bottle designed to be easy to grip, even with wet hands, and a visibility line so you can see the remaining quantity of the product.
Dr Melanie Rougier, corporate marketing manager at Ceva, said: “Our new range is the result of over 10 years of clients’ experience with Douxo and a robust programme of market research with four specific studies that included more than 2,000 vets and pet owners and represented over eight months of contact with pet owners. This has allowed us to gain a thorough understanding of our clients’ needs, in terms of performance, formulas, fragrance and ergonomic packaging."
Andrew Fullerton BVSc (Hons) MRCVS, product manager for Douxo at Ceva, added: "The new Douxo S3 range has been developed following extensive market research and field studies to ensure that the shampoos and mousses are not only innovative and effective, but that they are also safe and easy-to-use."
Dr Tim Nuttall BSc BVSc CertVD PhD CBiol MSB MRCVS, RCVS Specialist in Veterinary Dermatology and Senior Lecturer in Veterinary Dermatology at The Royal (Dick) School of Veterinary Studies at the University of Edinburgh, said: "I like that the performance has been proven on a basic science screening level and innovative skin model and then moving on to the in-field trials. This is what we would like to see from topical products."
Douxo S3 shampoo and mousses will automatically replace the current Douxo products via veterinary wholesalers and Ceva says it is working to convert other products in the Douxo range to S3.
For further information, contact cevauk@ceva.com, your local territory manager or visit https://www.douxo.com/uk/Pet-Skin-Care/douxo-s3.
The new guidance replaces Chapter 25 of the Supporting Guidance to the Code of Professional Conduct.
Routine Veterinary Practice describes the procedures and techniques performed on animals by veterinary surgeons (or veterinary nurses under their direction) in the course of their professional duties, which ensure the health and welfare of animals committed to their care.
CVR is when routine procedures are undertaken for the benefit of the animal/s, with the concurrent intention to generate new knowledge that benefits animals, such as developing new procedures, improving a diagnosis, changing a routine procedure, or comparing existing procedures.
While the idea of CVR is not new, this is the first time that the RCVS has provided specific guidance on it.
The guidance also introduces an obligation, which comes into effect on 1st September, to obtain ethics review for all studies where one would be expected to obtain permission from the owner/keeper of an animal prior to being enrolled, or when consent is needed for use of previously collected samples or the use of data from an animal.
The newly drafted Chapter 25 gives extra guidance on the following areas:
Chair of the Standards Committee and incoming RCVS President, Dr Melissa Donald (pictured right), said: “We hope that the guidance will inspire confidence in our veterinary colleagues at all levels to undertake treatment routes which develop veterinary knowledge as a whole, while still being for the benefit of the animal being treated.”
For further information or advice on whether a proposed procedure would be covered by the guidance, contact the Standards and Advice team via advice@rcvs.org.uk.
The new guidance will be found on the RCVS website from the 1st July: www.rcvs.org.uk/recognised
For further information in relation to ethics review of proposed veterinary clinical research studies, contact the Secretary to the RCVS Ethics Review Panel via ethics@rcvs.org.uk or visit www.rcvs.org.uk/ethics
Earlier this year, the company called on veterinary team members to nominate nurse colleagues who had gone beyond the call of duty, particularly since the outbreak of the COVID-19 pandemic.
And the winners are:
Claire Defries, VN Programme Leader at the College of Animal Welfare, who was instrumental in developing online training virtually overnight when the national lockdown was announced in order to support vet nurses in training and to enable third year students to sit their finals. She was also commended for the pastoral support she has provided to students during lockdown.
Ellie Tappenden from Albyn Veterinary Centre in Broxburn, was nominated for the long shifts she has been working before delivering regular medicines and ensuring that self-isolating clients are coping. She also created a local support network with other vets and organised a collection of spare PPE for the local hospital. She achieved this while managing her pain from Ehlers Danlos, a degenerative disease which she fights every day.
Tammy Jarvis from the RSPCA Block Fen Animal Centre in March was nominated for the exceptional support she has provided to all 105 patients at the RSPCA centre and the veterinary surgeon. With other staff furloughed, she has also taken on additional duties, including maintenance and grounds management, and has recently started sewing facemasks for the team.
Bethany Lavill (pictured right) from Etwall Vets in Derby was nominated for the wide range of additional duties she has taken on, including collecting animals from owners who are self-isolating; coming in after hours to check up on in-patients and supporting bereaved clients. She has gone over and above the call of duty on many occasions and still asks what more she can do to help.
Student vet nurse Shannon Mills from Leeds Colton Vets4Pets was nominated for being a major asset to the team over the last few months, despite a recent diagnosis of epilepsy. She has willingly covered a range of roles and recently nursed a critical care rabbit throughout the day, whilst manning reception. She even managed to pass her mock exam with flying colours during lockdown with little time to study.
Each of the five winners was rewarded with a Betty’s Gift Box, brimming with treats, including Betty’s champagne truffles, chocolate desires, Yorkshire tea and shortbread.
Animalcare Product Manager James Beaumont said: “We wanted our competition to highlight the fantastic contribution vet nurses around the country are making to their colleagues, clients and patients – but the number and quality of entries hugely exceeded our expectations.
"At such a difficult time, the positivity, passion and care that each nomination exuded made reading them a moving experience and selecting only five as winners was no easy task. We thank all those who took the time to nominate their amazing colleagues and thank every vet nurse who was nominated for their extraordinary commitment and dedication."
The clinic is being run by Liz Leece, an RCVS and EBVS Specialist in veterinary anaesthesia and analgesia, to offer bespoke pain management plans for clients.
Liz has more than 20 years’ experience in specialist anaesthesia and analgesia and has extensive experience managing dogs and cats with complex problems causing chronic pain.
Liz said: "Our pets are similar to humans in the sense that the longer they live, the greater the chance they will develop conditions causing chronic pain.
"The clinic is available for any pet referred by their primary care vet for management of chronic pain, including osteoarthritis and other orthopaedic conditions, neurological and cancer pain.
"Animals will be assessed and advice given on how the pain can be managed, including monitoring a pet’s response to different treatments and what to expect."
For more information, visit www.paragonreferrals.co.uk.
CardioCare is based on research carried out at the Purina Technology Center which explored how nutrients can support the ailing heart. First, a series of metabolomics studies identified metabolic changes that occur in MMVD. Then the company developed a ‘Cardiac Nutritional Blend’ to address these metabolic changes and evaluated it in a clinical study.
The main elements of the Cardiac Nutritional Blend include carnitine precursors, antioxidants and medium-chain triglycerides. Purina says the latter provides an alternative energy source that is easy for the struggling heart to use, something which is particularly important as the metabolomics research revealed that dogs with MMVD showed less efficient cardiac energy metabolism1.
The company highlights a 2019 clinical study, which showed that the Cardiac Nutritional Blend has the potential to delay disease progression in dogs with preclinical MMVD. Over the six-month study period, dogs with preclinical MMVD fed the Cardiac Nutritional Blend showed a reduction in left atrial size, while an equivalent group of dogs fed a control diet showed an increase. Additionally, none of the dogs fed the Cardiac Nutritional Blend progressed from stage B1 to B2 during the study, while 37% of dogs fed the control diet showed progression2.
Purina also says that while the research to date has focused on MMVD, the nutrients in CardioCare are recognised to be beneficial under conditions of cardiac stress and the diet may prove a useful tool to provide support in a wider range of conditions. The company recommends that the diet be considered as part of the management plan for any dog with cardiac insufficiency.
Dr Libby Sheridan, Purina Scientific Affairs Manager for the UK & Ireland, said: "Metabolomics research has the scope to drive huge advances in managing a range of conditions. We’re proud to be at the forefront of this exciting field and bring the benefits of our findings to vets in practice.
"CardioCare opens up a new avenue of support for patients with cardiac insufficiency and vets can use this diet as a tool to complement medical treatment."
CardioCare will be available from 30th June. Contact vettechline@purina.nestle.com for more information.
According to the study1, which looked at Chihuahuas treated in first opinion practice, ownership in the UK has increased over five-fold in the past decade from 1.0% of all puppies born in 2005 to 5.4% in 2016.
However, the study also found the breed was particularly susceptible to a number of health issues, including: dental disease (13.5%), obesity (5.9%) and retained baby teeth (5.7%).
Compared with other dogs, Chihuahuas were also more prone to aggression (4.2%), slipping kneecap (4.0%) and retained testicles (3.9%).
Dan O’Neill, senior lecturer at the RVC and author of the paper, said: "Chihuahuas are an old breed but the recent craze for them can cause some real welfare issues for this tiny dog. There is increasing evidence that unscrupulous breeders and dealers both inside and outside the UK are cashing in on this trend by making a lot of money but with little regard for the welfare of these puppies and breeding bitches."
Camilla Pegram, VetCompass epidemiologist at the RVC and co-author of the paper said: "Dental disease and retained baby teeth should be recognised as important health concerns for Chihuahuas, with preventative care for dental disease a key topic for discussion between vets and owners. In addition, many of the common or predisposed disorders, such as dental disease, retained baby teeth, sliding kneecap and retained testicle(s), often require surgical intervention. The Chihuahua’s small size increases its anaesthetic risk. Obesity has many detrimental effects, including increased anaesthetic risk, and aggression makes them challenging patients and pets, therefore nutrition, lifestyle and behaviour are also key areas for veterinary-owner discussions."
The full paper is open access: https://doi.org/10.1186/s12917-020-2258-1.
Reference:
Entitled ‘Managing mitral valve disease from start to finish’, the course will account for four hours’ CPD split into six short bite-size sessions which can be completed at your own pace.
The sessions are presented by Dr Mike Martin MVB DVC MRCVS, and business thought leader, Dr Alison Lambert BVSc CMRS MRCVS. They consist of a practical review of MVD both pre-clinically and clinically and how to diagnose and stage it following the new 2019 American College of Veterinary Internal Medicine (ACVIM) Consensus guidelines.
The course also includes tips on how to treat and manage dogs with MVD with diuretic management; a step-by-step guide to treatment options for acute and long-term management of congestive heart failure and how to troubleshoot problem congestive heart failure cases.
There's also a bonus ‘Communicating Cardiology’ session which looks at how to communicate the heart disease journey to owners.
To register for the course visit www.veterinarywebinars.com/mvd-reg.
Ceva will donate £2 for every veterinary professional completing the course throughout February and March 2021 to Vetlife, which provides support to the veterinary community and their families who have emotional, health or financial concerns.